Lacrinorm (Carbomer 980)

Carbomer 980 is a high‑molecular‑weight polymer that swells when mixed with water, forming a three‑dimensional gel matrix. This gel raises the viscosity of the tear film, slowing its drainage and allowing active ingredients to remain in contact with the cornea and conjunctiva for a longer period. The result is improved lubrication and better therapeutic efficacy without interacting with cellular receptors.

The specific dose of Lacrinorm is determined by the prescribing eye‑care professional based on the patient’s condition, severity, and treatment plan. Lacrinorm is typically administered as one or more drops to the affected eye(s) at the frequency recommended by the clinician. Patients should follow the prescriber’s instructions and not alter the dosing regimen on their own.

Safety data for Carbomer 980‑containing ophthalmic products during pregnancy and lactation are limited. As a precaution, the use of Lacrinorm in pregnant or nursing women should only be considered if the potential benefit outweighs any possible risk, and after consultation with a qualified healthcare provider.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity of Lacrinorm. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. After the enquiry, the sales team will request trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

The primary alternatives to Carbomer 980‑based viscosity agents are hyaluronic acid and carboxymethylcellulose eye drops. Compared with hyaluronic acid, Carbomer 980 typically provides a higher viscosity at lower concentrations, which can result in longer ocular surface retention. However, hyaluronic acid may be better tolerated in some patients with sensitivity to polymers. Choice of product depends on the clinician’s assessment of efficacy, tolerability, and patient preference.

Lacrinorm should be stored at ambient temperature, preferably below 25 °C, in its original container. Keep the bottle tightly closed, protect it from direct sunlight, and avoid exposure to moisture. Do not freeze the product. If the solution becomes cloudy or particles appear, discard it and obtain a new supply.

Lacrinorm is applied topically to the eye(s) as a sterile drop. The patient should wash their hands, tilt the head back, and gently pull down the lower eyelid to create a small pocket. One or more drops are placed into this pocket without touching the tip of the bottle to the eye or surrounding surfaces. The eye should be closed gently for a few seconds to allow distribution.

While most adverse events are mild, serious risks include allergic conjunctivitis, which may present as redness, swelling, and itching, and rare corneal epithelial defects that can compromise vision. Persistent intra‑ocular inflammation is another rare but serious concern. Patients experiencing any of these symptoms should discontinue use immediately and seek prompt ophthalmic evaluation.

Lacrinorm should be avoided in individuals with known hypersensitivity to Carbomer 980 or any other component of the formulation. Patients with active corneal ulcers, severe ocular infections, or compromised ocular barriers should not use the product until the underlying condition is resolved. As always, a qualified eye‑care professional should assess suitability before initiating therapy.